FOLH1 and posterior cortical atrophy: These modified PSMA-CAR-T cells constitutively expressing ICR exhibited markedly improved cytotoxicity and prolonged survival in mice compared with conventional PSMA-CAR-T cells, suggesting a promising new strategy for PCa treatment.